Dr. Ritesh Amin - Psychiatrist & TMS Therapy
35-37 Progress Street, Suite aa5, Edison
5.0(17 Google reviews)
United States
1 listed treatment center serving Perth Amboy and the surrounding area.
35-37 Progress Street, Suite aa5, Edison
5.0(17 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Perth Amboy.
10.6 miles away · Westfield
11 miles away · Elizabeth
230 West Jersey Street, 303, Elizabeth
13.5 miles away · Union
14.7 miles away · Maplewood
For people in Perth Amboy, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and the services billed. The medication and the visit for supervised dosing and monitoring may generate separate charges. Ask for an estimate that includes both, rather than a medication-only quote.
Prior authorization is common. Your insurer may ask the prescriber to document your diagnosis and earlier antidepressant trials, including which medications you took and how you responded. Bringing available treatment records can help the center prepare its request. Authorization is not a guarantee that every charge will be covered, so confirm your share of the costs separately.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. New Jersey Medicaid coverage also depends on the plan and treatment setting. Confirm both your benefits and whether the center accepts your coverage; a directory listing alone does not establish either.
Manufacturer savings programs exist for eligible commercially insured patients, but not for people using government insurance such as Medicare or Medicaid. Program rules apply, and assistance may not cover all visit-related charges.
Before starting, ask the center and insurer:
Request written benefit details and a billing contact for follow-up questions.
SPRAVATO® visits take place only in a healthcare setting certified through the Spravato REMS safety program. You administer the nasal spray yourself under direct observation; it is never supplied for home use. Before scheduling, ask the center to confirm its current certification and whether it is accepting new patients.
The typical labeled schedule starts with twice-weekly treatment during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber individualizes the schedule, so use this as a planning guide, not a promise about your treatment.
Allow at least two hours after each dose for monitoring, plus time for check-in and preparation. Some visits may take longer. If you work, discuss recurring time off or scheduling adjustments before treatment begins. Plan around caregiving responsibilities as well, and avoid commitments that depend on leaving at an exact time.
Arrange a driver for every visit: you cannot drive or operate machinery until the next day after a restful sleep. Ask a family member, friend, or another support person about recurring rides and a backup plan. If considering a hired ride, first ask the center about its discharge and escort requirements.
If no Perth Amboy listing is available or suitable, check listings in Edison, New Brunswick, Elizabeth, Newark, or Jersey City. These listings are starting points, not confirmation of REMS certification, appointment availability, or insurance acceptance. Contact each location directly before making travel arrangements.
Use SPRAVATO® directory listings as a starting point, then ask the center directly whether it is currently REMS-certified and accepting patients. A listing does not independently confirm certification. If a Perth Amboy option is unavailable or unsuitable, you can check listed locations in Edison or New Brunswick. Confirm insurance acceptance and ride requirements before booking.
Spravato is approved for adults with treatment-resistant depression, alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder and acute suicidal thoughts or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and health risks to determine whether it is appropriate.
Coverage depends on your plan and treatment setting. Prior authorization and records of earlier antidepressant trials are commonly requested. Ask about coverage for both the medication and the supervised monitoring visit, which may be billed separately. Medicare and New Jersey Medicaid may cover treatment depending on the plan and setting, but you must also confirm that the center accepts your coverage.
You use the nasal spray yourself under a healthcare provider’s direct observation in a REMS-certified setting. Staff monitor you for at least two hours after dosing, including checks for changes in alertness, breathing, and blood pressure. You cannot take the medication home. Someone else must drive you home, and you must not drive until the next day after a restful sleep.
Spravato can cause sedation, dissociation—a feeling of disconnection from yourself or your surroundings—breathing problems, and increased blood pressure. Its boxed warnings include sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your medical history, medications, and any substance-use concerns with the prescriber before treatment.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Even when prescribed for depressive symptoms associated with acute suicidal thoughts or behavior, emergency assessment may still be necessary. If you are in crisis, call or text 988. If there is immediate danger or a medical emergency, call 911.
Approved uses, nearby treatment centers, and medically sourced patient guides.